I seen what happened at $95, the FDA response, and how people responded to lockup expiration + the secondary offering. People reacted quickly, things got tense, and now the storm will soon calm. The point is, it very recently hit a new high, and a new high will happen likely really soon. Once $115 passes, my new target is $200. I believe this is feasible if single source FDA approval is within a timely manner. They also have factories and deployments. I am looking constantly at institutional activity, and that is what excites me the most trend-wise. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.